Publications found:
36,694
Sort by:
Bladder Prolapse (Cystocele) Market - 2024-2031
US$ 3,400.00
Bladder Prolapse (Cystocele) Marketis is growing with a CAGR of 8.30% during the forecast period 2026-2035. The Bladder Prolapse (Cystocele) Market emerges as a key focus in DataM Intelligence latest...
September 2023
54 pages
Follicular Thyroid Cancer Drug Market - 2024-2031
US$ 3,400.00
The Follicular Thyroid Cancer Drug Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to d...
September 2023
56 pages
End Stage Renal Disease Market - 2024-2031
US$ 3,400.00
End Stage Renal Disease Marketis is growing with a CAGR of 12.70% during the forecast period 2026-2035. The End Stage Renal Disease Market emerges as a key focus in DataM Intelligence latest in-depth...
September 2023
49 pages
Hashimoto's Thyroiditis Drug Market - 2024-2031
US$ 3,400.00
Hashimoto's Thyroiditis Drug Marketis is growing with a CAGR of 5.50% during the forecast period 2026-2035. The Hashimoto's Thyroiditis Drug Market emerges as a key focus in DataM Intelligence latest...
September 2023
54 pages
Postpartum Hemorrhage Treatment Market - 2024-2031
US$ 3,400.00
The Postpartum Hemorrhage Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to...
September 2023
57 pages
Antibody Discovery Services and Platforms Market (5th Edition): Distribution by Type of Service Offered (Antigen Designing, Hit Generation, Lead Selection, Lead Optimization, Lead Characterization), Antibody Discovery Method (Hybridoma based, Library based, Single Cell based, Transgenic Animal based), Type of Antibody Generated (Monoclonal Antibodies, Bispecific Antibodies and Others), Nature of Antibody Generated (Chimeric, Human, Humanized and Murine), Type of Therapeutic Areas (Cardiovascular Disorders, Immunological Disorders, Infectious Disorders, Neurological Disorders, Oncological Disorders and Others) and Key Geographies (North America, Europe, Asia, Latin America, Middle East and North Africa and Rest of the World): Industry Trends and Global Forecasts, 2023-2035
US$ 4,799.00
The global antibody discovery services and platforms market is expected to reach USD 1.6 billion by 2023 anticipated to grow at a CAGR of 12% during the forecast period 2023-2035. Developing drugs, fr...
September 2023
525 pages
Cystinuria Treatment Market - 2024-2031
US$ 3,400.00
Cystinuria Treatment Marketis is growing with a CAGR of 4.30% during the forecast period 2026-2035. The Cystinuria Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysi...
September 2023
46 pages
Diabetic Ketoacidosis Market - 2024-2031
US$ 3,400.00
Diabetic Ketoacidosis Marketis is growing with a CAGR of 5.80% during the forecast period 2026-2035. The Diabetic Ketoacidosis Market emerges as a key focus in DataM Intelligence latest in-depth analy...
September 2023
47 pages
Diabetic Neuropathic Pain Market - 2024-2031
US$ 3,400.00
Diabetic Neuropathic Pain Marketis is growing with a CAGR of 6.10% during the forecast period 2026-2035. The Diabetic Neuropathic Pain Market emerges as a key focus in DataM Intelligence latest in-dep...
September 2023
51 pages
Necrotizing Enterocolitis Drugs Market - 2024-2031
US$ 3,400.00
The Necrotizing Enterocolitis Drugs Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to...
September 2023
57 pages
Phosphoglucomutase (PGM 1) Deficiency Market - 2024-2031
US$ 3,400.00
The Phosphoglucomutase (PGM 1) Deficiency Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresig...
September 2023
63 pages
Asia Pacific Enteral and Parenteral Medical Nutrition Market Forecast to 2028 - Regional Analysis By Indication [Elderly, Gastrointestinal Disorders (IBD, IBS, and Others), Diabetes, Cancer, Respiratory Disorders, Alzheimer’s Disease, Dementia, Renal Disease, Liver Failure, Post COVID-19, and Other Indications], Nutrition Type (Supplemental and Sole Source), Form (Liquid, Powder, and Semi Solid), Product Type (General and Disease Specific), Route of Administration (Oral, Tube Feed, and Parenteral), Age Group (Above 60 Years, 18-60 Years, 3-18 Years, and Below 3 Years), and Distribution Channel (Hospital Pharmacies, Retail Stores, E-Commerce, and Others)
US$ 3,000.00
The Asia Pacific enteral and parenteral medical nutrition market is expected to grow from US$ 2,339.32 million in 2023 to US$ 3,352.69 million by 2028. It is estimated to grow at a CAGR of 7.5% from 2...
September 2023
348 pages
Europe Enteral and Parenteral Medical Nutrition Market Forecast to 2028 - Regional Analysis By Indication [Elderly, Gastrointestinal Disorders (IBD, IBS, and Others), Diabetes, Cancer, Respiratory Disorders, Alzheimer’s Disease, Dementia, Renal Disease, Liver Failure, Post COVID-19, and Other Indications], Nutrition Type (Supplemental and Sole Source), Form (Liquid, Powder, and Semi Solid), Product Type (General and Disease Specific), Route of Administration (Oral, Tube Feed, and Parenteral), Age Group (Above 60 Years, 18-60 Years, 3-18 Years, and Below 3 Years), and Distribution Channel (Hospital Pharmacies, Retail Stores, E-Commerce, and Others)
US$ 3,000.00
The Europe enteral and parenteral medical nutrition market is expected to grow from US$ 6,472.35 million in 2023 to US$ 9,054.89 million by 2028. It is estimated to grow at a CAGR of 6.9% from 2023 to...
September 2023
417 pages
Middle East & Africa Enteral and Parenteral Medical Nutrition Market Forecast to 2028 - Regional Analysis By Indication [Elderly, Gastrointestinal Disorders (IBD, IBS, and Others), Diabetes, Cancer, Respiratory Disorders, Alzheimer’s Disease, Dementia, Renal Disease, Liver Failure, Post COVID-19, and Other Indications], Nutrition Type (Supplemental and Sole Source), Form (Liquid, Powder, and Semi Solid), Product Type (General and Disease Specific), Route of Administration (Oral, Tube Feed, and Parenteral), Age Group (Above 60 Years, 18-60 Years, 3-18 Years, and Below 3 Years), and Distribution Channel (Hospital Pharmacies, Retail Stores, E-Commerce, and Others)
US$ 3,000.00
The Middle East & Africa enteral and parenteral medical nutrition market is expected to grow from US$ 539.80 million in 2023 to US$ 661.18 million by 2028. It is estimated to grow at a CAGR of 4.1% fr...
September 2023
335 pages
North America Enteral and Parenteral Medical Nutrition Market Forecast to 2028 - Regional Analysis By Indication [Elderly, Gastrointestinal Disorders (IBD, IBS, and Others), Diabetes, Cancer, Respiratory Disorders, Alzheimer’s Disease, Dementia, Renal Disease, Liver Failure, Post COVID-19, and Other Indications], Nutrition Type (Supplemental and Sole Source), Form (Liquid, Powder, and Semi Solid), Product Type (General and Disease Specific), Route of Administration (Oral, Tube Feed, and Parenteral), Age Group (Above 60 Years, 18-60 Years, 3-18 Years, and Below 3 Years), and Distribution Channel (Hospital Pharmacies, Retail Stores, E-Commerce, and Others)
US$ 3,000.00
The North America enteral and parenteral medical nutrition market is expected to grow from US$ 8,049.98 million in 2023 to US$ 11,030.78 million by 2028. It is estimated to grow at a CAGR of 6.5% from...
September 2023
217 pages
South & Central America Enteral and Parenteral Medical Nutrition Market Forecast to 2028 - Regional Analysis By Indication [Elderly, Gastrointestinal Disorders (IBD, IBS, and Others), Diabetes, Cancer, Respiratory Disorders, Alzheimer’s Disease, Dementia, Renal Disease, Liver Failure, Post COVID-19, and Other Indications], Nutrition Type (Supplemental and Sole Source), Form (Liquid, Powder, and Semi Solid), Product Type (General and Disease Specific), Route of Administration (Oral, Tube Feed, and Parenteral), Age Group (Above 60 Years, 18-60 Years, 3-18 Years, and Below 3 Years), and Distribution Channel (Hospital Pharmacies, Retail Stores, E-Commerce, and Others)
US$ 3,000.00
The South & Central America enteral and parenteral medical nutrition market is expected to grow from US$ 975.68 million in 2023 to US$ 1,377.32 million by 2028. It is estimated to grow at a CAGR of 7....
September 2023
336 pages
Pharmaceutical Quality Management Systems Market by Solution Type (Deviation, CAPA, Audit, Risk & Compliance, Inspection, Document, Change, Training Management), Deployment Mode (Cloud, On-premise), and End User (Pharmaceutical, CDMO/CRO) - Global Forecast to 2030
US$ 4,175.00
Pharmaceutical Quality Management Systems Market By Solution Type (Deviation, CAPA, Audit, Risk & Compliance, Inspection, Document, Change, Training Management), Deployment Mode (Cloud, On-premise), a...
September 2023
-
Pharmaceutical Grade Lithium Carbonate Market by Application (Extended Release, Immediate Release), Purity (99%, Above 99%), and Region (Asia Pacific, Europe, North America, Middle East & Africa, and South America) - Global Forecast to 2028
US$ 2,970.00
The pharmaceutical grade lithium carbonate market is projected to grow from USD 141 million in 2023 to USD 166 million by 2028, at a CAGR of 3.3% from 2023 to 2028. Lithium carbonate is commonly used...
September 2023
144 pages
Egypt Hyperlipidemia Drugs Market, By Drug Class (Statins, Bile Acid Sequestrants, Cholesterol Absorption Inhibitors, PCSK9 Inhibitors, Combination, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), By Region, Competition, Forecast, & Opportunities, 2028
US$ 3,500.00
Egypt hyperlipidemia drugs market is expected to grow at an impressive rate during the forecast period, 2024-2028. The major factors include increase in the prevalence of the condition, rising awarene...
September 2023
90 pages
Israel Generic Drugs Market, By Type (Pure Generic Drugs, Branded Generic Drugs), By Application (CNS, Cardiovascular, Dermatology, Genitourinary/Hormonal, Respiratory, Rheumatology, Diabetes, Oncology, and Others), By Drug Delivery (Oral, Injectables, Dermal/Topical, and Inhalers), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies), By Region, Competition, Forecast & Opportunities, 2028
US$ 3,500.00
Israel Generic Drugs Market is anticipated to witness substantial growth through 2028, owing to the incorporation of artificial intelligence (AI) in healthcare technologies for drug docking and prevai...
September 2023
80 pages
Israel ischemic heart disease (IHD) Drugs Market, Disease Class (Angina Pectoris, Myocardial Infarction), By Drug Class (Anti-Dyslipidemic Drugs, Calcium Channel Blockers, Beta-Blockers, ACE Inhibitors, ARBs, Vasodilators, Antithrombotic Agents), By Region, Competition, Forecast & Opportunities, 2028F
US$ 3,500.00
Israel ischemic heart disease (IHD) Drugs Market is expected to grow at an impressive rate during the forecast period, 2024-2028. The major factors include the rising prevalence of chronic diseases su...
September 2023
83 pages
Israel Over the Counter (OTC) Drugs Market By Product Type (Cough, Cold and Flu, Vitamins, Mineral, & Supplements (VMS), Analgesics, Gastrointestinal Products, Dermatology Products, Others), By Route of Administration (Oral, Topical, Parenteral, Others), By Dosage Form (Tablets, Capsules, Liquids & Solution, Creams/Lotions/Ointments, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, E-Pharmacies, Others), By Region, Competition, Forecast and Opportunities, 2028
US$ 3,500.00
Israel over the counter drugs market is expected to show an impressive growth during the forecast period, 2024-2028. The Israel over the counter drugs market is expected to boost due to the increasing...
September 2023
82 pages
Clinical Trials Market by Phase (Phase I, II, III), Service Type (Laboratory, Analytical Testing, Patient Recruitment, Protocol Designing), Therapeutic Area (Oncology, Cardiology, Neurology), and Application (Vaccine, mAbs, CGT) - Global Forecast to 2028
US$ 2,970.00
The global clinical trials market is projected to reach USD 73.2 billion by 2028 from USD 48.2 billion in 2023, at a CAGR of 8.7% during the forecast period of 2023 to 2028. The growth of this market...
September 2023
342 pages
Insulin Market Research (China)
US$ 4,000.00
China's demand for Insulin has grown at a fast pace in the past decade. In the next ... ) and/or US dollars. Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous ...
September 2023
220 pages
Brain Cancer Treatment Drugs Market Research (China)
US$ 4,000.00
China's demand for Brain Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next ... ) and/or US dollars. Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous ...
September 2023
234 pages
Secondary Hyperparathyroidism Treatment Market - 2024-2031
US$ 3,400.00
Secondary Hyperparathyroidism Treatment Marketis is growing with a CAGR of 9.20% during the forecast period 2026-2035. The Secondary Hyperparathyroidism Treatment Market emerges as a key focus in Data...
September 2023
65 pages
Co-development Deals in Pharmaceuticals and Biotechnology 2016 to 2023
US$ 3,995.00
... including big pharma such as Abbott, Abbvie, Actavis, Amgen, Astellas, AstraZeneca, Baxter, Bayer, Biogen Idec, BMS, Celgene, Eisai, Eli Lilly, Gilead, GSK, J&J, Kyowa Hakko, Merck, Mitsubishi, Mylan, Novartis, Pfizer, Roche ...
September 2023
350 pages
Collaboration Deals in Pharmaceuticals 2019-2023
US$ 3,995.00
... including big pharma such as Abbott, Abbvie, Actavis, Amgen, Astellas, AstraZeneca, Baxter, Bayer, Biogen Idec, BMS, Celgene, Eisai, Eli Lilly, Gilead, GSK, J&J, Kyowa Hakko, Merck, Mitsubishi, Mylan, Novartis, Pfizer, Roche ...
September 2023
1000 pages
Distribution Deals in Pharmaceuticals and Biotechnology 2016 to 2023
US$ 3,995.00
... DESCRIPTION The Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2019 report provides details of the latest distribution agreements announced in the pharmaceutical, biotechnology and ...
September 2023
500 pages
Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2023
US$ 3,995.00
... Joint venture alliances. KEY BENEFITS Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2019 provides the reader with the following key benefits: In-depth understanding of joint venture partnering deal ...
September 2023
200 pages
Licensing Deals in Pharmaceuticals 2019-2023
US$ 3,995.00
... latest licensing agreements announced in the pharmaceutical, biotechnology ... licensing deals by value since 2014 Most active licensing dealmakers since 2014 The leading licensing partnering resources In Global Licensing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014- 2019 available deals ...
September 2023
1200 pages
Royalty Rates in Pharmaceuticals and Biotechnology Deals
US$ 3,995.00
... including the technology licensed, royalty rates, license fees, upfront and milestone payments. DESCRIPTION The Global Royalty Rate Trends in Pharma ... licensed, royalty rates, license fees, upfront and milestone payments. This report provides details of the latest partnering deals which disclose a royalty rate ...
September 2023
500 pages
Pharmaceutical Contract Manufacturing Market Size, Share, and Analysis, By Molecule Type (Small Molecules, Large Molecules), By Service (Pharmaceutical Manufacturing Services, Pharmaceutical API Manufacturing Services, Pharmaceutical FDF Manufacturing Services, Drug Development Services, Biologic Manufacturing Services, Biologic API Manufacturing Services, Biologic FDF Manufacturing Services), By End User (Big Pharmaceutical Companies, Small & Mid-Sized Pharmaceutical Companies, Generic Pharmaceutical Companies, Other End Users [Academic Institutes, Small CDMOs, and CROs]) and Regional Forecasts, 2022-2032.
US$ 4,950.00
Pharmaceutical Contract Manufacturing Market Size, Share, and Analysis, By Molecule Type (Small Molecules, Large Molecules), By Service (Pharmaceutical Manufacturing Services, Pharmaceutical API Manuf...
September 2023
425 pages
Global Vitamin D Market 2023
US$ 2,950.00
The global vitamin D market is expected to rise by USD 76.3 million with a CAGR of 5.3% by the end of 2029. Key drivers of this growth include its application in nutricosmetics, premixes, functional b...
September 2023
89 pages
ADC Payload / Warheads Market: Distribution by Type of Product (Commercialized ADCs and Clinical ADCs), Type of Payload (Microtubule Inhibitors, DNA Damaging Agents, Topoisomerase Inhibitors and Others), Payload / Warhead (Auristatins, Calicheamicin, Camptothecin, Duocarmycin, Maytansinoids, Pyrrolobenzodiazepines and Others) and Geography (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, 2021-2035
US$ 4,799.00
ADC Payload / Warheads Market: Distribution by Type of Product (Commercialized ADCs and Clinical ADCs), Type of Payload (Microtubule Inhibitors, DNA Damaging Agents, Topoisomerase Inhibitors and Other...
September 2023
132 pages
AI in Drug Discovery Market (2nd Edition): Distribution by Drug Discovery Steps (Target Identification / Validation, Hit Generation / Lead Identification and Lead Optimization), Therapeutic Area (Oncological Disorders, CNS Disorders, Infectious Diseases, Respiratory Disorders, Cardiovascular Disorders, Endocrine Disorders, Gastrointestinal Disorders, Musculoskeletal Disorders, Immunological Disorders, Dermatological Disorders and Others) and Key Geographies (North America, Europe, Asia-Pacific, Latin America, MENA and Rest of the World): Industry Trends and Global Forecasts, 2022-2035
US$ 4,799.00
The AI in drug discovery market is expected to reach USD 0.74 billion by 2022 anticipated to grow at a CAGR of 25% during the forecast period 2022-2035. The journey of discovering and developing new t...
September 2023
387 pages
The Next Generation Drug Conjugates Market: Focus on GalNac Conjugate, Peptide Drug Conjugate, Peptide Oligonucleotide Conjugate, RNAi Conjugate, Peptide Receptor Radionuclide Therapy, Small Molecule-Drug Conjugate (SMDC), and Other Conjugates – Distribution by Type of Targeting Ligand (Amino Sugar, Lipid, Peptide, Small Molecule and Virus-like Particles), Type of Payload (Peptide, Small Molecule, Oligonucleotide and Radionuclide), Type of Therapy (Monotherapy and Combination Therapy), Route of Administration (Intravenous, Subcutaneous and Others), Mechanism of Action (sequence-specific target binding, radiation induced cytotoxicity, cancer-specific surface target mediated cytotoxicity, drug induced cytotoxicity, receptor mediated internalization and cytotoxicity and others) and Key Target Indications (Gastroenteropancreatic Neuroendocrine Tumors, Prostate Cancer, Leptomeningeal Carcinomatosis caused by Breast Cancer Brain Metastases, Hereditary Transthyretin Amyloidosis, Atherosclerotic Cardiovascular Diseases, Severe Hypertriglyceridemia, Hereditary Angioedema, Acute Hepatic Porphyria, Primary Hyperoxaluria, Heterozygous Familial Hypercholesterolemia, Hemophilia, Low-Risk Myelodysplastic Syndrome, Myelofibrosis, Alpha-1 Antitrypsin Deficiency Liver Disease and Familial Chylomicronemia Syndrome) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, 2023-2035
US$ 4,799.00
The global next generation drug conjugate market is anticipated to be valued at USD 15.47 billion in 2035 anticipated to grow at a CAGR of 18% during the forecast period 2023-2035. The next generation...
September 2023
120 pages
